ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
Europe - FRA:ILU - US4523271090 - Common Stock
104.92 EUR
+1.28 (+1.24%)
Overall ILU gets a fundamental rating of 6 out of 10. We evaluated ILU against 18 industry peers in the Life Sciences Tools & Services industry. ILU gets an excellent profitability rating and is at the same time showing great financial health properties. ILU is not valued too expensively and it also shows a decent growth rate. With these ratings, ILU could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
ILU had positive earnings in the past year.
ILU had a positive operating cash flow in the past year.
In multiple years ILU reported negative net income over the last 5 years.
In the past 5 years ILU always reported a positive cash flow from operatings.
1.2 Ratios
ILU has a better Return On Assets (20.67%) than 100.00% of its industry peers.
ILU has a better Return On Equity (55.71%) than 100.00% of its industry peers.
ILU has a Return On Invested Capital of 13.77%. This is amongst the best in the industry. ILU outperforms 94.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.67% | ||
| ROE | 55.71% | ||
| ROIC | 13.77% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 29.37%, ILU belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
ILU has a Operating Margin of 21.13%. This is amongst the best in the industry. ILU outperforms 94.44% of its industry peers.
ILU's Operating Margin has declined in the last couple of years.
ILU has a Gross Margin of 67.09%. This is amongst the best in the industry. ILU outperforms 94.44% of its industry peers.
In the last couple of years the Gross Margin of ILU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.13% | ||
| PM (TTM) | 29.37% | ||
| GM | 67.09% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ILU is creating some value.
The number of shares outstanding for ILU remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ILU has more shares outstanding
ILU has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.13 indicates that ILU is not in any danger for bankruptcy at the moment.
ILU has a better Altman-Z score (4.13) than 72.22% of its industry peers.
The Debt to FCF ratio of ILU is 1.93, which is an excellent value as it means it would take ILU, only 1.93 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.93, ILU belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
A Debt/Equity ratio of 0.66 indicates that ILU is somewhat dependend on debt financing.
ILU has a worse Debt to Equity ratio (0.66) than 61.11% of its industry peers.
Although ILU does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 1.93 | ||
| Altman-Z | 4.13 |
ROIC/WACC1.33
WACC10.33%
2.3 Liquidity
ILU has a Current Ratio of 1.81. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ILU (1.81) is better than 88.89% of its industry peers.
ILU has a Quick Ratio of 1.41. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of ILU (1.41) is better than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.41 |
3. Growth
3.1 Past
ILU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 152.02%, which is quite impressive.
Measured over the past years, ILU shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.93% on average per year.
Looking at the last year, ILU shows a decrease in Revenue. The Revenue has decreased by -2.32% in the last year.
The Revenue has been growing slightly by 4.29% on average over the past years.
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
3.2 Future
Based on estimates for the next years, ILU will show a very strong growth in Earnings Per Share. The EPS will grow by 23.91% on average per year.
ILU is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.67% yearly.
EPS Next Y87.51%
EPS Next 2Y42.21%
EPS Next 3Y32.55%
EPS Next 5Y23.91%
Revenue Next Year-1.43%
Revenue Next 2Y0.63%
Revenue Next 3Y2.46%
Revenue Next 5Y3.67%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 27.68, ILU can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of ILU is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.03. ILU is around the same levels.
A Price/Forward Earnings ratio of 24.33 indicates a rather expensive valuation of ILU.
The rest of the industry has a similar Price/Forward Earnings ratio as ILU.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.27, ILU is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.68 | ||
| Fwd PE | 24.33 |
4.2 Price Multiples
ILU's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, ILU is valued a bit cheaper than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.97 | ||
| EV/EBITDA | 16.18 |
4.3 Compensation for Growth
ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ILU has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ILU's earnings are expected to grow with 32.55% in the coming years.
PEG (NY)0.32
PEG (5Y)N/A
EPS Next 2Y42.21%
EPS Next 3Y32.55%
5. Dividend
5.1 Amount
No dividends for ILU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (11/4/2025, 7:00:00 PM)
104.92
+1.28 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners102.96%
Inst Owner ChangeN/A
Ins Owners0.18%
Ins Owner ChangeN/A
Market Cap16.13B
Revenue(TTM)4.29B
Net Income(TTM)1.26B
Analysts71.72
Price Target99.18 (-5.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.3%
Min EPS beat(2)1.33%
Max EPS beat(2)15.27%
EPS beat(4)3
Avg EPS beat(4)8.93%
Min EPS beat(4)-7.76%
Max EPS beat(4)26.88%
EPS beat(8)6
Avg EPS beat(8)115.88%
EPS beat(12)10
Avg EPS beat(12)231.91%
EPS beat(16)13
Avg EPS beat(16)178.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.21%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)-0.18%
Revenue beat(8)3
Avg Revenue beat(8)-0.63%
Revenue beat(12)4
Avg Revenue beat(12)-0.69%
Revenue beat(16)6
Avg Revenue beat(16)-0.56%
PT rev (1m)4.61%
PT rev (3m)3.83%
EPS NQ rev (1m)-0.46%
EPS NQ rev (3m)7.91%
EPS NY rev (1m)-0.28%
EPS NY rev (3m)6.44%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)1.02%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.68 | ||
| Fwd PE | 24.33 | ||
| P/S | 4.33 | ||
| P/FCF | 17.97 | ||
| P/OCF | 16.06 | ||
| P/B | 8.21 | ||
| P/tB | 20.43 | ||
| EV/EBITDA | 16.18 |
EPS(TTM)3.79
EY3.61%
EPS(NY)4.31
Fwd EY4.11%
FCF(TTM)5.84
FCFY5.56%
OCF(TTM)6.53
OCFY6.23%
SpS24.26
BVpS12.78
TBVpS5.14
PEG (NY)0.32
PEG (5Y)N/A
Graham Number33.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.67% | ||
| ROE | 55.71% | ||
| ROCE | 19.56% | ||
| ROIC | 13.77% | ||
| ROICexc | 18.36% | ||
| ROICexgc | 30.05% | ||
| OM | 21.13% | ||
| PM (TTM) | 29.37% | ||
| GM | 67.09% | ||
| FCFM | 24.07% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 1.93 | ||
| Debt/EBITDA | 1.26 | ||
| Cap/Depr | 44.24% | ||
| Cap/Sales | 2.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.55% | ||
| Profit Quality | 81.96% | ||
| Current Ratio | 1.81 | ||
| Quick Ratio | 1.41 | ||
| Altman-Z | 4.13 |
F-Score6
WACC10.33%
ROIC/WACC1.33
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.02%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%17.54%
EPS Next Y87.51%
EPS Next 2Y42.21%
EPS Next 3Y32.55%
EPS Next 5Y23.91%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%0.37%
Revenue Next Year-1.43%
Revenue Next 2Y0.63%
Revenue Next 3Y2.46%
Revenue Next 5Y3.67%
EBIT growth 1Y275.52%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year30.85%
EBIT Next 3Y15.15%
EBIT Next 5Y14.59%
FCF growth 1Y560.27%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y449.52%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%
ILLUMINA INC / ILU.DE FAQ
What is the ChartMill fundamental rating of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a fundamental rating of 6 / 10 to ILU.DE.
What is the valuation status of ILLUMINA INC (ILU.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILU.DE). This can be considered as Fairly Valued.
How profitable is ILLUMINA INC (ILU.DE) stock?
ILLUMINA INC (ILU.DE) has a profitability rating of 7 / 10.
What is the valuation of ILLUMINA INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ILLUMINA INC (ILU.DE) is 27.68 and the Price/Book (PB) ratio is 8.21.
What is the earnings growth outlook for ILLUMINA INC?
The Earnings per Share (EPS) of ILLUMINA INC (ILU.DE) is expected to grow by 87.51% in the next year.